Medicinal Products

Ozurdex

Name Ozurdex
Active Substance dexamethasone
Prescription na recept
Type of prescription ograničeni recept
Distribution u ljekarni
ATC Code S01BA01
Medicinal product marketed in the Croatia Da
Educational materials
for patients / caregivers
Vodic za bolesnike, verzija 2

Note

The medicinal product has been authorised via centralised procedure in all Member States of the European Union based on the European Medicines Agency's expert opinion. Additional information on the medicinal product can be found under the following link:https://www.ema.europa.eu/en/medicines/human/EPAR/ozurdex

The marketing authorisation has been granted by the European Commission. All marketing authorisations of the European Commission can be found under the following link: http://ec.europa.eu/health/documents/community-register/html/index_en.htm

Direct Healthcare Professional Communication

Name Date Download
Pismo zdravstvenim radnicima o uočenim silikonskim česticama tijekom rutinske vizualne inspekcije lijeka Ozurdex intravitrealni implantat (deksametazon) 11.10.2018 Allergan Pharmaceuticals Ireland
Pismo zdravstvenim radnicima o opskrbi tržišta novim, ispravnim serijama lijeka Ozurdex intravitrealni implantat (deksametazon) 12.04.2019 Allergan Pharmaceuticals Ireland
Pismo zdravstvenim radnicima s nastavnim informacijama o uočenim silikonskim česticama tijekom rutinske vizualne inspekcije lijeka Ozurdex intravitrealni implantat (deksametazon) 31.10.2018 Allergan Pharmaceuticals Ireland
Back